Personal Cfo Solutions, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Personal Cfo Solutions, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$9.76 - $13.41 $9,760 - $13,410	-1,000 Reduced 6.56%	14,238 $183,000
Q2 2022 Aug 05, 2022	SELL	$7.6 - $11.41 $15,200 - $22,820	-2,000 Reduced 11.6%	15,238 $148,000
Q4 2021 Feb 11, 2022	SELL	$10.39 - $15.15 $51,950 - $75,750	-5,000 Reduced 22.48%	17,238 $203,000
Q3 2021 Nov 18, 2021	SELL	$11.39 - $16.23 $48,977 - $69,789	-4,300 Reduced 16.2%	22,238 $253,000
Q2 2021 Jul 22, 2021	BUY	$13.22 - $19.09 $3,966 - $5,727	300 Added 1.14%	26,538 $370,000
Q4 2020 Feb 09, 2021	BUY	$14.8 - $21.15 $67,162 - $95,978	4,538 Added 20.91%	26,238 $463,000
Q3 2020 Nov 02, 2020	BUY	$15.21 - $25.53 $30,420 - $51,060	2,000 Added 10.15%	21,700 $0
Q1 2020 Apr 30, 2020	BUY	$11.0 - $19.76 $216,700 - $389,272	19,700 New	19,700 $305,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Personal Cfo Solutions, LLC with notifications on news.